Recent progress towards understanding the role of DNA methylation in human placental development

Tina Bianco-Miotto, Benjamin T. Mayne, Sam Buckberry, James Breen, Carlos M. Rodriguez Lopez, Claire T. Roberts

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Epigenetic modifications, and particularly DNA methylation, have been studied in many tissues, both healthy and diseased, and across numerous developmental stages. The placenta is the only organ that has a transient life of 9 months and undergoes rapid growth and dynamic structural and functional changes across gestation. Additionally, the placenta is unique because although developing within the mother, its genome is identical to that of the foetus. Given these distinctive characteristics, it is not surprising that the epigenetic landscape affecting placental gene expression may be different to that in other healthy tissues. However, the role of epigenetic modifications, and particularly DNA methylation, in placental development remains largely unknown. Of particular interest is the fact that the placenta is the most hypomethylated human tissue and is characterized by the presence of large partially methylated domains (PMDs) containing silenced genes. Moreover, how and why the placenta is hypomethylated and what role DNA methylation plays in regulating placental gene expression across gestation are poorly understood. We review genome-wide DNA methylation studies in the human placenta and highlight that the different cell types that make up the placenta have very different DNA methylation profiles. Summarizing studies on DNA methylation in the placenta and its relationship with pregnancy complications are difficult due to the limited number of studies available for comparison. To understand the key steps in placental development and hence what may be perturbed in pregnancy complications requires large-scale genome-wide DNA methylation studies coupled with transcriptome analyses.

LanguageEnglish
PagesR23-R30
JournalReproduction
Volume152
Issue number1
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Reproductive Medicine
  • Embryology
  • Endocrinology
  • Obstetrics and Gynaecology
  • Cell Biology

Cite this

Bianco-Miotto, T., Mayne, B. T., Buckberry, S., Breen, J., Rodriguez Lopez, C. M., & Roberts, C. T. (2016). Recent progress towards understanding the role of DNA methylation in human placental development. Reproduction, 152(1), R23-R30. https://doi.org/10.1530/REP-16-0014
Bianco-Miotto, Tina ; Mayne, Benjamin T. ; Buckberry, Sam ; Breen, James ; Rodriguez Lopez, Carlos M. ; Roberts, Claire T. / Recent progress towards understanding the role of DNA methylation in human placental development. In: Reproduction. 2016 ; Vol. 152, No. 1. pp. R23-R30.
@article{15b95e49050b4eee862ee2c7410efc7c,
title = "Recent progress towards understanding the role of DNA methylation in human placental development",
abstract = "Epigenetic modifications, and particularly DNA methylation, have been studied in many tissues, both healthy and diseased, and across numerous developmental stages. The placenta is the only organ that has a transient life of 9 months and undergoes rapid growth and dynamic structural and functional changes across gestation. Additionally, the placenta is unique because although developing within the mother, its genome is identical to that of the foetus. Given these distinctive characteristics, it is not surprising that the epigenetic landscape affecting placental gene expression may be different to that in other healthy tissues. However, the role of epigenetic modifications, and particularly DNA methylation, in placental development remains largely unknown. Of particular interest is the fact that the placenta is the most hypomethylated human tissue and is characterized by the presence of large partially methylated domains (PMDs) containing silenced genes. Moreover, how and why the placenta is hypomethylated and what role DNA methylation plays in regulating placental gene expression across gestation are poorly understood. We review genome-wide DNA methylation studies in the human placenta and highlight that the different cell types that make up the placenta have very different DNA methylation profiles. Summarizing studies on DNA methylation in the placenta and its relationship with pregnancy complications are difficult due to the limited number of studies available for comparison. To understand the key steps in placental development and hence what may be perturbed in pregnancy complications requires large-scale genome-wide DNA methylation studies coupled with transcriptome analyses.",
author = "Tina Bianco-Miotto and Mayne, {Benjamin T.} and Sam Buckberry and James Breen and {Rodriguez Lopez}, {Carlos M.} and Roberts, {Claire T.}",
year = "2016",
doi = "10.1530/REP-16-0014",
language = "English",
volume = "152",
pages = "R23--R30",
journal = "Reproduction",
issn = "1470-1626",
publisher = "BioScientifica Ltd.",
number = "1",

}

Bianco-Miotto, T, Mayne, BT, Buckberry, S, Breen, J, Rodriguez Lopez, CM & Roberts, CT 2016, 'Recent progress towards understanding the role of DNA methylation in human placental development', Reproduction, vol. 152, no. 1, pp. R23-R30. https://doi.org/10.1530/REP-16-0014

Recent progress towards understanding the role of DNA methylation in human placental development. / Bianco-Miotto, Tina; Mayne, Benjamin T.; Buckberry, Sam; Breen, James; Rodriguez Lopez, Carlos M.; Roberts, Claire T.

In: Reproduction, Vol. 152, No. 1, 2016, p. R23-R30.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recent progress towards understanding the role of DNA methylation in human placental development

AU - Bianco-Miotto, Tina

AU - Mayne, Benjamin T.

AU - Buckberry, Sam

AU - Breen, James

AU - Rodriguez Lopez, Carlos M.

AU - Roberts, Claire T.

PY - 2016

Y1 - 2016

N2 - Epigenetic modifications, and particularly DNA methylation, have been studied in many tissues, both healthy and diseased, and across numerous developmental stages. The placenta is the only organ that has a transient life of 9 months and undergoes rapid growth and dynamic structural and functional changes across gestation. Additionally, the placenta is unique because although developing within the mother, its genome is identical to that of the foetus. Given these distinctive characteristics, it is not surprising that the epigenetic landscape affecting placental gene expression may be different to that in other healthy tissues. However, the role of epigenetic modifications, and particularly DNA methylation, in placental development remains largely unknown. Of particular interest is the fact that the placenta is the most hypomethylated human tissue and is characterized by the presence of large partially methylated domains (PMDs) containing silenced genes. Moreover, how and why the placenta is hypomethylated and what role DNA methylation plays in regulating placental gene expression across gestation are poorly understood. We review genome-wide DNA methylation studies in the human placenta and highlight that the different cell types that make up the placenta have very different DNA methylation profiles. Summarizing studies on DNA methylation in the placenta and its relationship with pregnancy complications are difficult due to the limited number of studies available for comparison. To understand the key steps in placental development and hence what may be perturbed in pregnancy complications requires large-scale genome-wide DNA methylation studies coupled with transcriptome analyses.

AB - Epigenetic modifications, and particularly DNA methylation, have been studied in many tissues, both healthy and diseased, and across numerous developmental stages. The placenta is the only organ that has a transient life of 9 months and undergoes rapid growth and dynamic structural and functional changes across gestation. Additionally, the placenta is unique because although developing within the mother, its genome is identical to that of the foetus. Given these distinctive characteristics, it is not surprising that the epigenetic landscape affecting placental gene expression may be different to that in other healthy tissues. However, the role of epigenetic modifications, and particularly DNA methylation, in placental development remains largely unknown. Of particular interest is the fact that the placenta is the most hypomethylated human tissue and is characterized by the presence of large partially methylated domains (PMDs) containing silenced genes. Moreover, how and why the placenta is hypomethylated and what role DNA methylation plays in regulating placental gene expression across gestation are poorly understood. We review genome-wide DNA methylation studies in the human placenta and highlight that the different cell types that make up the placenta have very different DNA methylation profiles. Summarizing studies on DNA methylation in the placenta and its relationship with pregnancy complications are difficult due to the limited number of studies available for comparison. To understand the key steps in placental development and hence what may be perturbed in pregnancy complications requires large-scale genome-wide DNA methylation studies coupled with transcriptome analyses.

UR - http://www.scopus.com/inward/record.url?scp=84976883193&partnerID=8YFLogxK

U2 - 10.1530/REP-16-0014

DO - 10.1530/REP-16-0014

M3 - Review article

VL - 152

SP - R23-R30

JO - Reproduction

T2 - Reproduction

JF - Reproduction

SN - 1470-1626

IS - 1

ER -